A phase iii, double-blind, placebo-controlled flexible-dose study of levomilnacipran sr in patients with major depressive disorder

The requested reference [6f101d7e74dd756abfe31c52bfda3a93521c75f6] no longer exists in our database. It has been replaced by the current reference: [118a2be01149c07c62366755f4350b8105a3c8bc]

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2012
This article has no abstract
Epistemonikos ID: 841f74986ac8d96dfcc5160afa2a2a0af245ac12
First added on: Apr 30, 2026